Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Greene

Showing results (641-650 of 761) with videos related to

Pageof 77
Sort By:
Journal of Neurotrauma|December 20, 2023
Phenotyping Depression After Mild Traumatic Brain Injury: Evaluating the Impact of Multiple Injury, Gender, and Injury ContextEamonn Kennedy, Mustafa Ozmen, Erin D Bouldin, et al.
American Journal of Obstetrics and Gynecology|February 26, 2022
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group studyPhuong L Mai, Austin Miller, Amanda Black, et al.
Gynecologic Oncology|November 25, 2019
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG studyPhuong L Mai, Helen Q Huang, Lari B Wenzel, et al.
JNCI Cancer Spectrum|April 28, 2020
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)Phuong L Mai, Austin Miller, Mitchell H Gail, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 11, 2012
Association of histologic variants in FSGS clinical trial with presenting features and outcomesVivette D D'Agati, Joan M Alster, J Charles Jennette, et al.
JCO Precision Oncology|December 29, 2021
Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing StudyAlexander Pemov, Talia Wegman-Ostrosky, Jung Kim, et al.
Familial Cancer|July 18, 2009
Younger age-at-diagnosis for familial malignant testicular germ cell tumorPhuong L Mai, Bingshu E Chen, Kathy Tucker, et al.
Gynecologic Oncology|February 14, 2017
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group studyPhuong L Mai, Marion Piedmonte, Paul K Han, et al.
Kidney International|December 24, 2010
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
Leukemia|January 30, 2020
In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigreesAlexander Pemov, Anand Pathak, Samantha J Jones, et al.
Pageof 77

Showing results (641-650 of 761) with videos related to

Sort By:
Pageof 77
Journal of Neurotrauma|December 20, 2023
Phenotyping Depression After Mild Traumatic Brain Injury: Evaluating the Impact of Multiple Injury, Gender, and Injury ContextEamonn Kennedy, Mustafa Ozmen, Erin D Bouldin, et al.
American Journal of Obstetrics and Gynecology|February 26, 2022
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group studyPhuong L Mai, Austin Miller, Amanda Black, et al.
Gynecologic Oncology|November 25, 2019
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG studyPhuong L Mai, Helen Q Huang, Lari B Wenzel, et al.
JNCI Cancer Spectrum|April 28, 2020
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)Phuong L Mai, Austin Miller, Mitchell H Gail, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 11, 2012
Association of histologic variants in FSGS clinical trial with presenting features and outcomesVivette D D'Agati, Joan M Alster, J Charles Jennette, et al.
JCO Precision Oncology|December 29, 2021
Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing StudyAlexander Pemov, Talia Wegman-Ostrosky, Jung Kim, et al.
Familial Cancer|July 18, 2009
Younger age-at-diagnosis for familial malignant testicular germ cell tumorPhuong L Mai, Bingshu E Chen, Kathy Tucker, et al.
Gynecologic Oncology|February 14, 2017
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group studyPhuong L Mai, Marion Piedmonte, Paul K Han, et al.
Kidney International|December 24, 2010
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
Leukemia|January 30, 2020
In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigreesAlexander Pemov, Anand Pathak, Samantha J Jones, et al.
Pageof 77